Product Information
DOXEPIN 50 MG CAPSULE is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $0.1535 per EA under NDC 72205009091. Its NADAC has been published 162 times since Jul 19, 2023.
FDA first approved this application on Jun 24, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Novadoz Pharmaceuticals LLCNDC
72205009091
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215113FDA Approved
6/24/2022
TE Code
AB
On Market Since
6/27/2022
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN 50 MG CAPSULE has been published 162 times since Jul 19, 2023, and over the history we have for it it has declined 43.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1535 per EA |
|---|---|
| All-time high | $0.2848 (Mar 13, 2024) |
| All-time low | $0.1165 (Nov 20, 2024) |
| 52-week high | $0.1606 |
| 52-week low | $0.1441 |
| Median price | $0.1727 |
| Average price | $0.1845 |
| Largest weekly change | -37.5% (Nov 20, 2024) |
| Weeks tracked | 162 |
| Tracking since | Jul 19, 2023 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXEPIN 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 50 MG CAPSULE, manufactured by Novadoz Pharmaceuticals LLC, is $0.1535 per EA (NDC 72205009091), effective Aug 19, 2026.
How has the price of DOXEPIN 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOXEPIN 50 MG CAPSULE has declined 43.2%. It has been tracked across 162 weekly CMS publications since Jul 19, 2023.
What are the highest and lowest recorded NADAC prices for DOXEPIN 50 MG CAPSULE?
Since Jul 19, 2023, the NADAC for DOXEPIN 50 MG CAPSULE has ranged from a low of $0.1165 (Nov 20, 2024) to a high of $0.2848 (Mar 13, 2024), with a median of $0.1727 per EA.
Are there cheaper alternatives to DOXEPIN 50 MG CAPSULE?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOXEPIN 50 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures DOXEPIN 50 MG CAPSULE?
DOXEPIN 50 MG CAPSULE (NDC 72205009091) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.